NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR THE UNITED STATES OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.
This announcement is not a prospectus or admission document and not an offer of shares for sale in any jurisdiction, including in or into Australia, Canada, Japan, South Africa or the United States.
Neither this announcement nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction. Investors should not subscribe for or purchase any shares referred to in this announcement except solely on the basis of the information contained in an Aquis Stock Exchange Growth Market admission document in final form (together with any supplementary admission document, if relevant, the "Admission Document"), including the risk factors set out therein, that may be published by SuperSeed Capital Limited in connection with Admission (as defined below).
DATE: 26 January 2022
SuperSeed Capital Limited
("SuperSeed Capital" or the "Company")
Announcement of successful fundraising and admission on the AQSE Stock Exchange
SuperSeed Capital Limited, a company established as a Venture Capital fund of funds for early-stage technology investing announces that it has successfully raised gross proceeds of £2,000,000 in a placing and subscription (the "Fundraising").
The Company, following the closing of its Fundraising, published its Admission Document on 26 January 2022.
The Admission Document relates to the admission of the Company's Ordinary Shares to trading on the Access segment of the Aquis Stock Exchange ("Admission").
The Admission Document will shortly be available on the Company's website at https://www.superseed.com/investors/superseed-capital/ .
Highlights:
· SuperSeed Capital will invest in early-stage UK B2B tech companies primarily through funds managed by SuperSeed Ventures LLP ("SuperSeed Ventures").
· SuperSeed Capital benefits:
o Early-stage tech investing offers potential for high multiple returns to investors
o Diversified portfolio provides a diversified approach to early stage technology investing
o Compatible with SIPPs and ISAs for sophisticated investors
· The Investment Manager's team, the SuperSeed Ventures team, has two decades of operational experience in Artificial Intelligence ("AI"), Software-as-a-Service ("SaaS") and B2B sales, having built and sold multiple companies as entrepreneurs and investors in Software, AI and Digital Services.
· SuperSeed Ventures seeks to invest primarily in:
o B2B SaaS; SuperSeed Ventures' management believes this area is attractive because of the potential for a recurring revenue stream and for cost-effective distribution to a global audience;
o Artificial Intelligence; which is a crucial enabler of the 'fourth industrial revolution' and has the potential to disrupt nearly every sector in every country, therefore the management sees AI as one of the most exciting growth areas; and
o Data; since data is the most crucial ingredient to AI's development and along with originators of unique datasets used for AI are becoming increasingly valuable.
· SuperSeed Ventures launched Fund I in 2019. Fund I invests in companies which have a market-ready, or nearly market-ready product and where significant value can be unlocked if the company can create a scalable, profitable and repeatable sales and distribution model.
· SuperSeed Capital will be the first AIC (Association of Investment Companies) member to be admitted to AQSE Growth Market.
Admission and the commencement of unconditional dealings is expected to take place at 8.00 a.m. (UK time) on 31 January 2022.
VSA Capital Limited ("VSA Capital") have been appointed as AQSE Corporate Adviser and Broker to the Company.
ENDS
For more information, please contact:
SuperSeed Capital Limited |
+44 (0)20 3405 3060 |
Mads Jensen, Investment Manager |
mads@superseed.com |
|
|
VSA Capital - AQSE Corporate Adviser and Broker |
+44(0)20 3005 5000 |
Corporate Finance: Andrew Raca |
ipo@vsacapital.com |
Corporate Broking: Andrew Monk, Peter Mattsson, David Scriven |